postpci圍手術(shù)期抗血小板策略-項美香16張課件_第1頁
postpci圍手術(shù)期抗血小板策略-項美香16張課件_第2頁
postpci圍手術(shù)期抗血小板策略-項美香16張課件_第3頁
postpci圍手術(shù)期抗血小板策略-項美香16張課件_第4頁
postpci圍手術(shù)期抗血小板策略-項美香16張課件_第5頁
已閱讀5頁,還剩27頁未讀, 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認(rèn)領(lǐng)

文檔簡介

post_pci圍手術(shù)期抗血小板策略_項美香21、靜念園林好,人間良可辭。22、步步尋往跡,有處特依依。23、望云慚高鳥,臨木愧游魚。24、結(jié)廬在人境,而無車馬喧;問君何能爾?心遠(yuǎn)地自偏。25、人生歸有道,衣食固其端。post_pci圍手術(shù)期抗血小板策略_項美香post_pci圍手術(shù)期抗血小板策略_項美香21、靜念園林好,人間良可辭。22、步步尋往跡,有處特依依。23、望云慚高鳥,臨木愧游魚。24、結(jié)廬在人境,而無車馬喧;問君何能爾?心遠(yuǎn)地自偏。25、人生歸有道,衣食固其端。post-PCI圍手術(shù)期抗血小板策略浙江大學(xué)醫(yī)學(xué)院附屬第二醫(yī)院心內(nèi)科項美香ACC/AHA/SCAIFocusedUpdateoftheGuidelineforPercutaneousCoronaryIntervention

2007WritingCommitteeMembersSpencerB.KingIII,MD,MACC,FAHA,FSCAI,Co-ChairSidneyC.Smith,MD,FACC,FAHA,Co-ChairJohnW.Hirshfeld,Jr,MD,FACC,FAHA,FSCAIAliceK.Jacobs,MD,FACC,FAHA,FSCAIDouglassA.Morrison,MD,PhD,FACC,FSCAIDavidO.Williams,MD,FACC,FAHA,FSCAIpost_pci圍手術(shù)期抗血小板策略_項美香21、靜念園林好1postpci圍手術(shù)期抗血小板策略_項美香16張課件2postpci圍手術(shù)期抗血小板策略_項美香16張課件3postpci圍手術(shù)期抗血小板策略_項美香16張課件4postpci圍手術(shù)期抗血小板策略_項美香16張課件5AntiplateletTherapy

Patientsalreadytakingdailylong-termaspirinshouldtake75mgto325mgbeforePCI.

Nochanges

Patientsnotalreadytakingdailyaspirinshouldbegiven300mgto325mgofaspirinatleast2hoursandpreferably24hoursbeforePCI.

Nochange AfterPCI,inpatientswithoutallergyorincreasedriskofbleeding,aspirin162mgto325mgdailyshouldbegivenforatleast: 1monthafterBMS 3monthsaftersirolimus-elutingstent 6monthsafterpaclitaxel-elutingstent

Modifiedrecommendation

IIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIAntiplateletTherapy 6Aspirin Allpost-PCIstentedpatientswithoutaspirinresistance,allergy,orincreasedriskofbleedingshouldbegivenaspirin162mgto325mgdailyforatleast: 1monthafterBMS 3monthsaftersirolimus-elutingstent 6monthsafterpaclitaxel-elutingstent

Long-termaspirinuseshouldbecontinuedindefinitelyat75mgto162mgdaily.

Modifiedrecommendation Inpatientsatincreasedriskofbleeding,lower-dose75mgto162mgofaspirinisreasonableduringtheinitialperiodafterstentimplantation.

NewrecommendationIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIAspirin Allpost-PCIstentedp7Aspirin2006ConsensusofChina:ASA100~300mgq.d.afterPCIatleast1month.Andthen75~100mgq.d.Aspirin8AspirinNotrialscomparedlowerdose(75-162mg)withhigherdoseaspirin(162-325mg)astheinitialcourseoftherapyafterDESinsubacuteorlatestentthrombosisTherecommendationaccordingtotheclinicaltrialprotocolHigherdoseaspirinincreasetheriskofbleedingInthepatientsathighriskofbleeding,theuseoflowdoseofaspirin.AspirinNotrialscomparedlowe9AspirinMajorbleedingeventsweremorefrequentlyinpatientsoftakingSA200mg+clopidogrel75mgthanthatoftakingASA100mg+clopidogrel75mgAntiplateleteffectscouldnotbeincreasedinhigherdoseofASAAspirin10Clopidogrel Forallpost-PCIpatientswhoreceiveaDES,clopidogrel75mgdailyshouldbegivenforatleast12monthsifnotathighriskofbleeding.Forpost-PCIpatientsreceivingasBMS,itshouldbegivenforaminimumof1monthandideallyupto12months(unlesspatientisatincreasedriskofbleedingthenitshouldbegivenforaminimumof2weeks).

Modifiedrecommendation Forallpost-PCInon-stentedSTEMIpatients,treatmentwithclopidogrelshouldcontinuefor14days.

Newrecommendation Long-termmaintenancetherapy(e.g.1year)withclopidogrelisreasonableinSTEMIandNSTEMIwhoundergoPCIwithoutreperfusiontherapy.

NewrecommendationIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIClopidogrel Forallpost-PCI11PerioperativeperiodUnderurgentsituation,thedurationstudiedforFDAapproval3monthsforSES6monthsforPESPerioperativeperiodUnderurge12PredictorsoflatestentthrombosisSmallvesselsMultiplelesionsLongstentsOverlappingstentsOstialorbifurcationlesionsSuboptimalstentresultLowEFAdvancedageDMRenalfailureASCPredictorsoflatestentthrom13PerioperativeperiodElectivesurgery:postponedfor1yearNotbedeferredsurgery,aspirintherapyconsideredinhighriskpatientswithDESSurgerywithlowriskofbleeding,continueDATPerioperativeperiodElectives14謝謝謝謝15謝謝46、我們?nèi)粢呀邮茏顗牡?,就再沒有什么損失?!突?/p>

47、書到用時方恨少、事非經(jīng)過不知難?!懹?/p>

48、書籍把我們引入最美好的社會,使我們認(rèn)識各個時代的偉大智者?!访罓査?/p>

49、熟讀唐詩三百首,不會作詩也會吟?!獙O洙

50、誰和我一樣用功,誰就會和我一樣成功?!刂x謝46、我們?nèi)粢呀邮茏顗牡?,就再沒有什么損失?!突?6post_pci圍手術(shù)期抗血小板策略_項美香21、靜念園林好,人間良可辭。22、步步尋往跡,有處特依依。23、望云慚高鳥,臨木愧游魚。24、結(jié)廬在人境,而無車馬喧;問君何能爾?心遠(yuǎn)地自偏。25、人生歸有道,衣食固其端。post_pci圍手術(shù)期抗血小板策略_項美香post_pci圍手術(shù)期抗血小板策略_項美香21、靜念園林好,人間良可辭。22、步步尋往跡,有處特依依。23、望云慚高鳥,臨木愧游魚。24、結(jié)廬在人境,而無車馬喧;問君何能爾?心遠(yuǎn)地自偏。25、人生歸有道,衣食固其端。post-PCI圍手術(shù)期抗血小板策略浙江大學(xué)醫(yī)學(xué)院附屬第二醫(yī)院心內(nèi)科項美香ACC/AHA/SCAIFocusedUpdateoftheGuidelineforPercutaneousCoronaryIntervention

2007WritingCommitteeMembersSpencerB.KingIII,MD,MACC,FAHA,FSCAI,Co-ChairSidneyC.Smith,MD,FACC,FAHA,Co-ChairJohnW.Hirshfeld,Jr,MD,FACC,FAHA,FSCAIAliceK.Jacobs,MD,FACC,FAHA,FSCAIDouglassA.Morrison,MD,PhD,FACC,FSCAIDavidO.Williams,MD,FACC,FAHA,FSCAIpost_pci圍手術(shù)期抗血小板策略_項美香21、靜念園林好17postpci圍手術(shù)期抗血小板策略_項美香16張課件18postpci圍手術(shù)期抗血小板策略_項美香16張課件19postpci圍手術(shù)期抗血小板策略_項美香16張課件20postpci圍手術(shù)期抗血小板策略_項美香16張課件21AntiplateletTherapy

Patientsalreadytakingdailylong-termaspirinshouldtake75mgto325mgbeforePCI.

Nochanges

Patientsnotalreadytakingdailyaspirinshouldbegiven300mgto325mgofaspirinatleast2hoursandpreferably24hoursbeforePCI.

Nochange AfterPCI,inpatientswithoutallergyorincreasedriskofbleeding,aspirin162mgto325mgdailyshouldbegivenforatleast: 1monthafterBMS 3monthsaftersirolimus-elutingstent 6monthsafterpaclitaxel-elutingstent

Modifiedrecommendation

IIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIAntiplateletTherapy 22Aspirin Allpost-PCIstentedpatientswithoutaspirinresistance,allergy,orincreasedriskofbleedingshouldbegivenaspirin162mgto325mgdailyforatleast: 1monthafterBMS 3monthsaftersirolimus-elutingstent 6monthsafterpaclitaxel-elutingstent

Long-termaspirinuseshouldbecontinuedindefinitelyat75mgto162mgdaily.

Modifiedrecommendation Inpatientsatincreasedriskofbleeding,lower-dose75mgto162mgofaspirinisreasonableduringtheinitialperiodafterstentimplantation.

NewrecommendationIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIIIaIIaIIaIIbIIbIIbIIIIIIIIIAspirin Allpost-PCIstentedp23Aspirin2006ConsensusofChina:ASA100~300mgq.d.afterPCIatleast1month.Andthen75~100mgq.d.Aspirin24AspirinNotrialscomparedlowerdose(75-162mg)withhigherdoseaspirin(162-325mg)astheinitialcourseoftherapyafterDESinsubacuteorlatestentthrombosisTherecommendationaccordingtotheclinicaltrialprotocolHigherdoseaspirinincreasetheriskofbleedingInthepatientsathighriskofbleeding,theuseoflowdoseofaspirin.AspirinNotrialscomparedlowe25AspirinMajorbleedingeventsweremorefrequentlyinpatientsoftakingSA200mg+clopidogrel75mgthanthatoftakingASA100mg+clopidogrel75mgAntiplateleteffectscouldnotbeincreasedinhigherdoseofASAAspirin26Clopidogrel Forallpost-PCIpatientswhoreceiveaDES,clopidogrel75mgdailyshouldbegivenforatleast12monthsifnotathighriskofbleeding.Forpost-PCIpatientsreceivingasBMS,itshouldbegivenforaminimumof1monthandideallyupto12months(unlesspatientisatincreasedriskofbleedingthenitshouldbegivenforaminimumof2weeks).

Modifiedrecommendation Forallpost-PCInon-stentedSTEMIpatients,treatmentwithclopidogrelshouldcontinuefor14days.

Newrecommendation Long-termmaintenancetherapy(e.g.1year)withclopidogrelisreasonableinSTEMIandNSTEMIwhoundergoPCIwithoutreperfusiontherapy.

NewrecommendationIIIIIaIIaIIaIIbIIbIIbIIIIII

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

最新文檔

評論

0/150

提交評論